Genetically blocking HPD via CRISPR-Cas9 protects against lethal liver injury in a pig model of tyrosinemia type I.
Gu P, Yang Q, Chen B, Bie YN, Liu W, Tian Y, Luo H, Xu T, Liang C, Ye X, Liu Y, Tang X, Gu W.
Gu P, et al. Among authors: bie yn.
Mol Ther Methods Clin Dev. 2021 Apr 9;21:530-547. doi: 10.1016/j.omtm.2021.04.002. eCollection 2021 Jun 11.
Mol Ther Methods Clin Dev. 2021.
PMID: 33997102
Free PMC article.